Serum Biomarkers in Parkinson's Disease at Different Stages
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
Study identifier: NCT05769699. Status: RECRUITING. Phase: NA.
Eligibility
Criteria: Inclusion Criteria: * Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria; * Age: 18-80 years; * Signature of informed consent to participate in this study Exclusion criteria. * Women pregnant * Inflammatory or autoimmune diseases
- Minimum age: 18 Years
- Maximum age: 80 Years
Participating locations
- Flavia Torlizzi, Roma
Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.